Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
11500mg mesalazine pellets
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬
2250mg mesalazine pellets
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬
3500mg mesalazine pellets
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬
4750mg mesalazine pellets
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬
5Azathioprine OR Mesalazine
(D00377)
[2] Azathioprine,
Mesalazine
[2] Azathioprine ,
Mesalamine (D00377) 💬
--[1] 96 💬
6Conventional treatment (glucocoticoid, immunosupressive drugs and/or mesalazine)
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[2] 96, 97 💬
7Delayed and extended release mesalazine
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬
8Mesalazine
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[3] 46, 96, 97 💬
9Mesalazine (3,600 mg)
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬
10Mesalazine (Asacol®)
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬
11Mesalazine (Mesalamine)
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 96 💬
12Mesalazine - TID 1000 mg
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬
13Mesalazine - TID 2x 500 mg
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬
14Mesalazine 1000 mg gastro-resistant tablets
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬
15Mesalazine 250Mg
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬
16Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet
(D00377)
[2] Mesalazine,
Nitazoxanide
[2] Mesalamine (D00377),
Nitazoxanide 💬
--[1] 97 💬
17Mesalazine 4G Enema
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬
18Mesalazine 500 mg gastro-resistant tablets (Salofa
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬
19Mesalazine 500 mg gastro-resistant tablets (Salofalk® 500 mg)
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬
20Mesalazine EC 500 mg
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 96 💬
21Mesalazine Enema
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬
22Mesalazine liquid enema
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬
23Mesalazine slow-release granules
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬
24Mesalazine Sustained-Release Tablets
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 96 💬
25Mesalazine tablet
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬
26Mesalazine tablets
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 96 💬
27Mesalazine with hydrocortisone sodium succinate
(D00377)
[2] Hydrocortisone,
Mesalazine
[2] Hydrocortisone ,
Mesalamine (D00377) 💬
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
28Mesalazine, Tripterygium glycosides
(D00377)
[2] Mesalazine,
Tripterygium wilfordii whole
[1] Mesalamine (D00377) 💬--[1] 96 💬
29MMX mesalamine/ mesalazine
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬
30MMX Mesalamine/Mesalazine
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬
31MMX Mesalamine/Mesalazine (High Dose)
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬
32MMX Mesalamine/Mesalazine (Low Dose)
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬
33Overencapsulated mesalazine tablets
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬
34SPD476 (mesalazine)
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬
35SPD476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine
(D00377)
[1] Mesalazine[1] Mesalamine (D00377) 💬--[1] 97 💬